Cargando…
Pipeline shield with single antiplatelet therapy in aneurysmal subarachnoid haemorrhage: multicentre experience
BACKGROUND: The Pipeline Embolisation Device with Shield technology (PED-Shield) is suggested to have reduced thrombogenicity. This reduced thrombogenicity may make it possible to use safely in the acute treatment of aneurysmal subarachnoid haemorrhage (aSAH) on single antiplatelet therapy (SAPT). O...
Autores principales: | Manning, Nathan W, Cheung, Andrew, Phillips, Timothy J, Wenderoth, Jason D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582735/ https://www.ncbi.nlm.nih.gov/pubmed/30552166 http://dx.doi.org/10.1136/neurintsurg-2018-014363 |
Ejemplares similares
-
Periprocedural to 1-year safety and efficacy outcomes with the Pipeline Embolization Device with Shield technology for intracranial aneurysms: a prospective, post-market, multi-center study
por: Rice, Hal, et al.
Publicado: (2020) -
Use of the pCONus HPC as an adjunct to coil occlusion of acutely ruptured aneurysms: early clinical experience using single antiplatelet therapy
por: Aguilar Perez, Marta, et al.
Publicado: (2020) -
Prospective study on embolization of intracranial aneurysms with the pipeline device: the PREMIER study 1 year results
por: Hanel, Ricardo A, et al.
Publicado: (2020) -
Prospective study on embolization of intracranial aneurysms with the pipeline device (PREMIER study): 3-year results with the application of a flow diverter specific occlusion classification
por: Hanel, Ricardo A, et al.
Publicado: (2023) -
Patient and aneurysm factors associated with aneurysm recanalization after coiling
por: Pierot, Laurent, et al.
Publicado: (2022)